SCHEMBL4658288

SCHEMBL4658288

O=[N+]([O-])c1ccc2nc(N3CCOCC3)cc(Cl)c2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.56
ALDH1A1 P00352 4/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2C9 P11712 1/20 0.52
HPGD P15428 1/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
MAPK1 P28482 1/20 0.47
POLB P06746 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
CYP3A4 P08684 1/20 0.47
SLC6A4 P31645 1/20 0.47
CYP2C19 P33261 1/20 0.47
THPO P40225 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6365676 0.85 ALDH1A1 (0.66) ALDH1A1CYP1A2HTR3EHTR3BCYP3A4
Hydrochloric Acid SCHEMBL6372638 0.84 ALDH1A1 (0.65) ALDH1A1CYP1A2HTR3EHTR3BCYP3A4
SCHEMBL6365101 0.83 ALDH1A1 (0.46) ACHEALDH1A1CYP1A2KMT2ATDP1
SCHEMBL3559642 0.80 ALDH1A1 (0.72) ACHEALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL4658305 0.79 ALDH1A1 (0.53) ACHEALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL3555470 0.78 ALDH1A1 (0.61) ACHEALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL29937693 0.74 ALDH1A1 (0.68) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL2103553 0.74 ALDH1A1 (0.68) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL30894837 0.74 KMT2A (0.55) ACHEALDH1A1MEN1KMT2A
SCHEMBL4658369 0.74 KMT2A (0.55) ACHEALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819342-A4 QUINOLINE TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2008-12-17 EP disclosed
US-20070293492-A1 Quinoline Tachykinin Receptor Antagonists MERCK SHARP & DOHME CORP. 2007-12-20 US disclosed
EP-1819342-A1 QUINOLINE TACHYKININ RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2007-08-22 EP disclosed
WO-2006060390-A1 QUINOLINE TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293492-A1 Quinoline Tachykinin Receptor Antagonists TACR1, TACR2, NPSR1 ACHE 619/4885ALDH1A1 874/4885CYP1A2 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.